DMRA · Damora Therapeutics, Inc.
$32.44
+0.64 (+2.01%)
At close · Aug 19
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.97B
Shares
61.74M
No listed options were found for DMRA.
Key facts
CIK
1800315
CUSIP
G2646Y104
13F (30d)
104 filings
103 filers
Visit website
Investor relations